A Study Of Ursolic Acid For Primary Sclerosing Cholangitis
NCT03216876
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Lack of feasibility
Conditions
Primary Sclerosing Cholangitis
Interventions
DRUG:
Ursolic acid
Sponsor
University of California, Davis